» Articles » PMID: 35928889

Kisspeptin in the Prediction of Pregnancy Complications

Overview
Specialty Endocrinology
Date 2022 Aug 5
PMID 35928889
Authors
Affiliations
Soon will be listed here.
Abstract

Kisspeptin and its receptor are central to reproductive health acting as key regulators of the reproductive endocrine axis in humans. Kisspeptin is most widely recognised as a regulator of gonadotrophin releasing hormone (GnRH) neuronal function. However, recent evidence has demonstrated that kisspeptin and its receptor also play a fundamental role during pregnancy in the regulation of placentation. Kisspeptin is abundantly expressed in syncytiotrophoblasts, and its receptor in both cyto- and syncytio-trophoblasts. Circulating levels of kisspeptin rise dramatically during healthy pregnancy, which have been proposed as having potential as a biomarker of placental function. Indeed, alterations in kisspeptin levels are associated with an increased risk of adverse maternal and foetal complications. This review summarises data evaluating kisspeptin's role as a putative biomarker of pregnancy complications including miscarriage, ectopic pregnancy (EP), preterm birth (PTB), foetal growth restriction (FGR), hypertensive disorders of pregnancy (HDP), pre-eclampsia (PE), gestational diabetes mellitus (GDM), and gestational trophoblastic disease (GTD).

Citing Articles

Renal autocrine neuropeptide FF (NPFF) signaling regulates blood pressure.

Lee H, Amatya B, Villar V, Asico L, Jeong J, Feranil J Sci Rep. 2024; 14(1):15407.

PMID: 38965251 PMC: 11224344. DOI: 10.1038/s41598-024-64484-9.


[Notch1/Akt/Foxo1 Pathway Regulated by Kisspeptin Is Involved in Endometrial Decidualization in Patients With Recurrent Spontaneous Abortion].

Yang Y, Zhang J, Li D, Liu C, Guo R, Xiao Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(3):542-551.

PMID: 38948287 PMC: 11211770. DOI: 10.12182/20240560206.


Diagnostic utility of clinicodemographic, biochemical and metabolite variables to identify viable pregnancies in a symptomatic cohort during early gestation.

Hill C, Phelan M, Dutton P, Busuulwa P, Maclean A, Davison A Sci Rep. 2024; 14(1):11172.

PMID: 38750192 PMC: 11096363. DOI: 10.1038/s41598-024-61690-3.


Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction.

Sliwowska J, Woods N, Alzahrani A, Paspali E, Tate R, Ferro V J Diabetes. 2024; 16(4):e13541.

PMID: 38599822 PMC: 11006622. DOI: 10.1111/1753-0407.13541.


The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome.

Salmeri N, Vigano P, Cavoretto P, Marci R, Candiani M Rev Endocr Metab Disord. 2023; 25(2):239-257.

PMID: 37505370 DOI: 10.1007/s11154-023-09826-0.


References
1.
Taran F, Kagan K, Hubner M, Hoopmann M, Wallwiener D, Brucker S . The Diagnosis and Treatment of Ectopic Pregnancy. Dtsch Arztebl Int. 2015; 112(41):693-703. PMC: 4643163. DOI: 10.3238/arztebl.2015.0693. View

2.
Jayasena C, Abbara A, Izzi-Engbeaya C, Comninos A, Harvey R, Gonzalez Maffe J . Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. 2014; 99(12):E2652-60. PMC: 4255122. DOI: 10.1210/jc.2014-1953. View

3.
Qiao C, Wang C, Shang T, Lin Q . [Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates]. Zhonghua Fu Chan Ke Za Zhi. 2005; 40(9):585-90. View

4.
Adali E, Kurdoglu Z, Kurdoglu M, Kamaci M, Kolusari A, Yildizhan R . Metastin levels in pregnancies complicated by pre-eclampsia and their relation with disease severity. J Matern Fetal Neonatal Med. 2012; 25(12):2671-5. DOI: 10.3109/14767058.2012.708369. View

5.
Bowe J, King A, Kinsey-Jones J, Foot V, Li X, OByrne K . Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats. Diabetologia. 2009; 52(5):855-62. DOI: 10.1007/s00125-009-1283-1. View